Showing results (891-900 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|March 24, 2026
Evaluating pozelimab in the treatment of CHAPLE diseaseNecmiye Keser Ozturk, Durmus Burak Demirkaya, Alper Bulutoglu, et al.Immunotherapy|April 14, 2026
Efficacy of first-line immune checkpoint inhibitors for recurrent/metastatic head and neck cancer: a systematic review and meta-analysisJiuli Zhou, Wenbo Tang, Liqiong XueImmunotherapy|April 21, 2026
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumabAli Kaan Güren, Nazım Can Demircan, Özge Gümüşay, et al.Immunotherapy|May 16, 2026
Recent developments in nanotechnology-enhanced immunotherapy for glioblastomaDavide Frumento, Ștefan ȚăluImmunotherapy|April 20, 2026
Evaluating oral nutritional support and the nutritional risk scores in ICI-treated metastatic solid tumoursCaner Acar, Gökhan Şahin, Haydar Çağatay Yüksel, et al.Immunotherapy|April 16, 2026
The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectivesPhillip N Perez, Illaa Smesseim, Daniel H StermanImmunotherapy|April 28, 2026
Pembrolizumab combined with chemotherapy for advanced or metastatic non-small cell lung cancer with low PD-L1 expression: a systematic review and meta-analysis of randomized controlled trialsAkhil Deepak Vatvani, Gilbert Lazarus, Reyad Al Jabiri, et al.Immunotherapy|April 25, 2026
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysisZixuan Zhang, Kehui Meng, Meiyu Wu, et al.Immunotherapy|May 12, 2026
Clinical determinants and biomarkers for predicting chemotherapeutic response in advanced non-small cell lung cancer: a single-center retrospective studyLing Zhang, Wei Li, Yidong Wang, et al.Immunotherapy|May 28, 2026
Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancerSoumendu Patra, Harshita Shand, Suvankar GhoraiPageof 190